Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
AAid, accomplished, accretion, accretive, ALK, Amgen, assumption, ASU, Athene, attention, backlog, began, bench, binary, biomarker, Blueprint, Boerner, bridge, Bulletin, Burgundy, Center, Chancery, Cheplapharm, Christopher, clearance, CMS, concurrently, conjunction, consecutively, constrained, consummate, consummated, consummation, content, correspondingly, CreditWatch, dabigatran, devoting, difficulty, disaggregation, East, Eastern, EMAC, entirety, EQ, expedite, export, Fargo, foregoing, genomic, GILTI, GlaxoSmithKline, graph, harbor, hiring, histology, hormone, Hub, implicit, implied, ingested, Intercon, interdependent, interrelated, intravenously, Janssen, Kentucky, lapse, linked, loan, LP, managerial, mCRPC, megabase, merged, minute, misappropriation, motivate, motivating, necessarily, Nektar, OCE, overdraft, owed, pain, PDUFA, Pegbelfermin, pendency, PI, pilot, plaque, pomalidomide, predominantly, preliminary, premium, proteasome, protocol, read, reclassification, redeployed, Relatlimab, requisite, resign, resignation, retention, rivaroxaban, robust, RTOR, satisfaction, Shareowner, standstill, Starboard, stipulated, styled, talent, thrombotic, TMB, tradeable, tranche, unchanged, UPSA, user, waived, waiver, whistleblower, workdown, XIa
Removed:
Affordable, allegedly, Amira, API, Asian, assured, ASV, atrial, Avenue, Bydureon, Caldarella, capable, charged, Chester, collectability, constructing, coordinate, DCV, defer, dispute, divested, documented, element, establish, evident, executed, fibrillation, filling, Fitch, genotype, HCV, idiopathic, immunosuppressive, incurring, infection, intolerant, irbesartan, ixabepilone, Ixempra, Joseph, juvenile, lacking, leukemia, Likewise, lock, measurable, meslylate, Myalept, OCI, outlook, par, park, participated, PDL, percent, persuasive, postemployment, potent, preferred, Recothrom, released, rheumatoid, SA, shipped, similarly, sofosbuvir, stopped, submitted, supplied, Symlin, tender, undelivered, unfavorable, unrealized, updated, Valeant, variability, Venezuela, virology
Filing tables
Filing exhibits
Related press release
Associated BMY transcripts
BMY similar filings
Filing view
External links
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 33-33682, 33-62496, 033-61147, 333-49227, 333-114107, 333-117818, 333-150471, 333-182852, 333-206991, 333-65444 and 333-227304 on Form S-3, No. 333-229464 on Form S-4 and Nos. 33-30856, 33-38411, 33-38587, 33-44788, 333-47403, 33-52691, 33-30756-02, 33-58187, 333-02873, 333-65424, 333-107414, 333-144893 and 333-182405 on Form S-8 of our reports dated February 25, 2019, relating to the consolidated financial statements and financial statement schedules of Bristol-Myers Squibb Company and subsidiaries (the "Company") and the effectiveness of the Company's internal control over financial reporting, appearing in this Annual Report on Form 10-K of Bristol-Myers Squibb Company for the year ended December 31, 2018.
/s/ DELOITTE & TOUCHE LLP
Parsippany, NJ
February 25, 2019
E-23-1